SCHEMBL25554530

SCHEMBL25554530

CC(C)NCCNCCCO

nearest known ligand 0.31

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.31
KDM4E B2RXH2 2/20 0.31
CNR1 P21554 1/20 0.31
ADRA1A P35348 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
ARG1 P05089 1/20 0.31
ARG2 P78540 1/20 0.31
ALDH1A1 P00352 2/20 0.31
CASP2 P42575 1/20 0.31
TSHR P16473 1/20 0.31
MEN1 O00255 1/20 0.31
GLA P06280 1/20 0.31
CYP2C19 P33261 1/20 0.31
KMT2A Q03164 1/20 0.31
POLB P06746 1/20 0.30
ABCC3 O15438 1/20 0.30
ADRB2 P07550 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2474075 0.85 LMNA (0.33) LMNAKDM4ECNR1ADRA1ATDP1
SCHEMBL95613 0.85
SCHEMBL25566216 0.82 CYP2C19 (0.41) LMNAKDM4ETDP1ARG1ARG2
Hydrochloric Acid SCHEMBL1551987 0.82
SCHEMBL17766693 0.82 LMNA (0.32) LMNAKDM4ETDP1ALDH1A1
SCHEMBL4745076 0.82 LMNA (0.32) LMNAKDM4ETDP1ALDH1A1
SCHEMBL17766691 0.82 LMNA (0.32) LMNAKDM4ETDP1ALDH1A1
SCHEMBL4746164 0.82 LMNA (0.32) LMNAKDM4ETDP1ALDH1A1
SCHEMBL4745112 0.82 LMNA (0.32) LMNAKDM4ETDP1ALDH1A1
SCHEMBL10617948 0.81 ALDH1A1 (0.37) LMNAKDM4EALDH1A1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159532-A1 PARATHYROID HORMONE (PTH) RECEPTOR ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159532-A1 PARATHYROID HORMONE (PTH) RECEPTOR ANTAGONISTS AND USES THEREOF PTH1R, CALCR, VDR LMNA 1955/4885KDM4E 4704/4885CNR1 788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.